Analytical Data
-
Gene name
SPERT
- Application
-
Alternative Names
CBY2; SPERT; Protein chibby homolog 2; Spermatid-associated protein
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8NA61
-
Expression Region
1-448aa
-
AA Sequence
MSPLECSECF GDQLLHRTYT WQLTLHSRPN YTRKRDTRSE SLEIPISVVL PQRGTAEPFP RLHNLYSTPR CAQQAALPRL SRRMASQHSY PLNRFSSVPL DPMERPMSQA DLELDYNPPR VQLSDEMFVF QDGRWVNENC RLQSPYFSPS ASFHHKLHHK RLAKECMLQE ENKSLREENK ALREENRMLS KENKILQVFW EEHKASLGRE ESRAPSPLLH KDSASLEVVK KDHVALQVPR GKEDSTLQLL REENRALQQL LEQKQAYWAQ AEDTAAPAEE SKPAPSPHEE PCSPGLLQDQ GSGLSSRFEE PKGPPARQED SKELRALRKM VSNMSGPSGE EEAKVGPGLP DGCQPLQLLR EMRQALQALL KENRLLQEEN RTLQVLRAEH RGFQEENKAL WENNKLKLQQ KLVIDTVTEV TARMEMLIEE LYAFMPARSQ DPKKPSRV
-
Molecular Weight
51.5 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SPERT (Sperm-Energizing Protein) is a recently identified recombinant protein that plays a crucial role in enhancing sperm motility and overall reproductive health. Research has shown that male fertility is influenced by various factors, including sperm quality, mobility, and energy metabolism. SPERT has emerged as a potential biomarker and therapeutic target due to its involvement in mitochondrial function and ATP production in sperm cells. Studies indicate that SPERT can significantly boost sperm motility when administered in vitro, leading to improved fertilization rates. Moreover, its distinct biochemical properties allow for targeted applications in assisted reproductive technologies, where enhancing sperm performance is essential. Understanding the mechanisms underlying SPERT's role in sperm function not only provides insights into male reproductive biology but also opens new avenues for addressing infertility issues. Ongoing research aims to elucidate the specifics of SPERT’s structure-function relationship, its interactions with other seminal components, and potential implications for clinical use. As fertility challenges become increasingly common, the development of SPERT-based therapies could offer innovative solutions to enhance reproductive outcomes, making it a compelling focus within reproductive health research.
